Treatment
Medical therapy clinical trials
We’re tracking 954 recruiting studies that include Medical therapy, each written for real people, not researchers, below.
Recruiting studies
- NCT04190862RecruitingPhase 1
Cell therapy for simple anal fistulas
This Phase 1 study tests whether a donated-cell treatment (given with a minor procedure) can help heal simple anal fistulas. It mainly focuses on safety first, but may also look at how well the fistula closes.
New York, New YorkAges 18 years+ - NCT04563507RecruitingPhase 2
Immunotherapy plus hormone therapy for metastatic ER-positive breast cancer
This Phase 2 study tests a combination of immune-based treatments along with hormone (endocrine) therapy to slow or shrink advanced, hormone-receptor positive, HER2-negative breast cancer. You may be a candidate if your cancer has progressed after standard hormone-blocking medicines and you can start treatment with CDK4/6 medicine plus an aromatase inhibitor.
New York, New YorkAges 18–90 - NCT04662970Recruiting
Imaging after a heart device to optimize pacing settings
This study uses a heart MRI (a special scan) to better map the heart’s electrical activity, with the goal of fine-tuning settings on your implanted pacing device. It’s meant to improve how well the device coordinates your heartbeat.
Innsbruck, TyrolAges 18 years+ - NCT04769362RecruitingPhase 4
Checking long-term beta-blocker use after a heart attack
This study looks at people who have already been on a beta-blocker for at least a year after a heart attack. It aims to understand how long-term beta-blocker treatment affects heart health and outcomes.
SeoulAges 19 years+ - NCT05374681Recruiting
Test a minimally invasive add-on treatment for brain vessel swelling
This trial studies whether an add-on, minimally invasive procedure works better than standard care for a specific brain blood-vessel problem (CSH) that is larger than 10 mm. It may help reduce symptoms or prevent worsening, if you meet the size and location requirements.
Amiens, FranceAges 18 years+ - NCT05513872RecruitingPhase 1/Phase 2
Help to quit smoking using nicotine replacement while not quitting yet
This early-stage study tests ways to help adults who currently smoke daily start making progress toward quitting (or changing smoking habits) over the next 6 months. You may use nicotine replacement, and the study checks safety for people who can use it.
Chicago, IllinoisAges 18 years+ - NCT06383026Recruiting
Hormone Therapy Breast Cancer Screening Pilot
This pilot study tests a new way to screen for breast cancer in people who have taken hormone therapy (like estrogen, progesterone, or testosterone). It aims to include both men and women between 40 and 75, and younger people (30-39) with a family history of breast cancer.
Milwaukee, WisconsinAges 30–75 - NCT06500169Recruiting
Golf exercise study for prostate cancer survivors
This study tests if golf can help men with prostate cancer feel better and stay healthy. It's for men who are on hormone therapy and want to try a gentle, fun exercise.
Los Angeles, CaliforniaAges 55–85 - NCT06707012RecruitingPhase 4
Metformin plus antidepressants for depression in obesity
This trial tests whether adding metformin (a diabetes medicine) to usual antidepressant treatment can help improve depression in people who are overweight or obese. It is for adults age 18–44 who are newly diagnosed with depression and do not have diabetes.
Karachi, SindhAges 18–45 - NCT06721286RecruitingPhase 2
Combining immunotherapy with chemotherapy before surgery for bile duct cancer
This trial tests whether adding an immunotherapy drug (toripalimab) to standard chemotherapy before surgery can improve outcomes for people with intrahepatic cholangiocarcinoma that can be surgically removed. It's for patients who haven't had prior treatment for their cancer and are in good overall health.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06954155RecruitingPhase 3
Tenecteplase for stroke treatment 24-72 hours after symptoms start
This trial tests if the clot-busting drug tenecteplase can help people with a moderate to severe stroke when given 24 to 72 hours after symptoms began. It aims to see if this later treatment window can improve recovery and reduce disability.
BeijingAges 18 years+ - NCT06996756RecruitingPhase 1
Gene therapy for alpha-1 antitrypsin deficiency
This trial tests a gene therapy to fix the genetic cause of alpha-1 antitrypsin deficiency, aiming to stop or slow emphysema. It is for people with the most common harmful gene variants who have mild to moderate lung damage and are otherwise healthy enough to take steroids safely.
New York, New YorkAges 18–70 - NCT07469098RecruitingPhase 2
Group vs individual MDMA therapy for PTSD after Oct 7
This study compares MDMA-assisted therapy in a group setting versus individual sessions for people whose PTSD started after the October 7, 2023 events in Israel. You would receive MDMA along with therapy sessions to see which format works best for reducing PTSD symptoms.
BeershebaAges 18–75 - NCT07488247RecruitingPhase 3
Light-Activated Gel for Diabetic Foot Ulcers
This trial tests a gel containing a light-activated drug (chlorin E6) for diabetic foot ulcers. The gel is applied to the ulcer and then activated with a special light to help the wound heal. It may be a good option if you have a foot ulcer that hasn't healed in 6 weeks or more.
Karachi, SindhAges 18 years+ - NCT00992303Recruiting
Collecting tissue samples during radiation for people with cancer
This study collects tissue samples from people with cancer while they are getting radiation therapy. It also includes healthy participants, to help researchers compare samples and better understand cancer and treatment.
Dallas, TexasAges 18 years+ - NCT06435598Recruiting
Video education for insulin use in diabetes
This study tests whether watching short videos on your smartphone can help people with diabetes better manage their insulin therapy. It may be a good fit if you take insulin, have a smartphone, and want to learn more about your treatment.
Dhulikhel, BagmatiAges 18–70 - NCT06632093Recruiting
Combination therapy for advanced liver cancer after standard treatment fails
This trial tests a triple combination of liver-directed chemotherapy (HAIC) plus immunotherapy (PD-1 inhibitor) and targeted therapy (Lenvatinib) for people with advanced liver cancer that has spread into the portal vein and who have already tried and failed standard treatments.
Shenyang, LiaoningAges 18–75 - NCT07756307Recruiting
Shock wave therapy for calcium deposits in the shoulder
This trial tests whether a non-invasive treatment called shock wave therapy can reduce pain and improve function in people with calcium deposits in the shoulder tendon. It uses sound waves to break up the deposits, which may relieve pain and help you move better.
Taipei, TaipeiAges 20–70 - NCT06467565RecruitingPhase 2
NALIRIFOX chemotherapy for locally advanced pancreatic cancer
This trial tests a combination of chemotherapy drugs (NALIRIFOX) as a first treatment for people with locally advanced pancreatic cancer that hasn't spread. The goal is to see if it can shrink the tumor and improve outcomes.
Nanjing, JiangsuAges 18–70 - NCT07313215Recruiting
Study of rifampin combo therapy for staph joint infections
This study tests whether adding rifampin to standard antibiotics works better for people with a staph infection in a joint replacement. It aims to find a more effective treatment for this type of infection.
Fuzhou, FujianAges 18–80 - NCT04430790RecruitingPhase 3
Doxapram for apnea in very preterm babies on breathing support
This trial studies whether the medicine doxapram can better treat breathing pauses (apnea) in very preterm babies who are already on breathing support in the NICU. It aims to reduce the need for extra interventions and improve outcomes in this high-risk group.
Brussels, Avenaue Hippocrate 10Ages 5 months–7 months - NCT05779917RecruitingPhase 1
CAR-T cells for cancers that have specific target proteins
This Phase 1 trial tests a customized immune therapy (CAR-T cells) for advanced cancers that have the proteins mesothelin, GPC3, and/or GUCY2C. It may help your body better recognize and kill cancer cells, but early-phase trials mainly focus on safety and learning how well the treatment works.
Guangzhou, GuangdongAges 18–75 - NCT06325813Recruiting
TMS therapy for ADHD in teens
This study tests if a type of brain stimulation called TMS can help teenagers with ADHD control their impulses better. The treatment targets a part of the brain that helps with stopping or changing actions.
Cincinnati, OhioAges 12–17 - NCT06617663Recruiting
Online therapy for teens: is it as good as usual care?
This study compares online therapy (ACT or EMDR) to usual care for teens aged 12–18. It aims to see if online sessions work just as well as in-person treatment.
Alkmaar, North HollandAges 12–18
Common questions
- Are there clinical trials studying Medical therapy?
- Yes. Clin2 currently lists 954 recruiting studies that include Medical therapy, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medical therapy trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medical therapy an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medical therapy or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.